<DOC>
	<DOC>NCT00804973</DOC>
	<brief_summary>This is a Phase 2, multicenter, randomized, double-blind, placebo and active comparator-controlled study of LY2590443 in approximately 200 subjects with migraines.</brief_summary>
	<brief_title>Study in Subjects With Acute Migraines Headaches.</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Male and female subjects between the ages of 18 and 65 years, inclusive. Subjects who have migraine headaches, with or without aura (diagnosis according the International Classification of Headache DisordersII), for at least 1 year. Subjects who have had 28 migraine attacks on average per month for the last 3 months (but less than 15 headache days per month). Subjects who are willing and able to comply with the study schedule and requirements. Subjects who speak, read and understand English sufficiently well and are willing to provide written informed consent. Subjects who in the opinion of the principal investigator are in good general health. Venous access should be sufficient to allow blood sampling as per protocol. Subjects who do not or may not tolerate 5HT1 agonist treatments, with known hypersensitivity to sumatriptan (as discussed with the investigator). Female subjects who have a positive pregnancy test at screening or pre dose evaluation, or are breastfeeding. History or presence of significant medical illnesses as determined by the investigator. Subjects with a current clinical diagnosis of major psychiatric disease. Regular use of known drugs of abuse; use of opiates for migraine rescue (no more than two times per month) is permissible. Blood donation of 500mL or greater of whole blood products within 4 weeks of study commencement, during the study, or 4 weeks following the study. Investigator site personnel directly affiliated with this study and their immediate families. Immediate family is defined as a spouse, parent, child or sibling, whether biological or legally adopted. Consumption of more than three units of alcohol per day where one unit is defined as a 12 oz beer, 4 oz wine, or 2 oz of alcohol spirit liquor. Are unwilling or unable to comply with the use of a diary to directly record data from the subject.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
</DOC>